China Epoprostenol Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Epoprostenol Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Sale Channel
1.3 China Epoprostenol Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Epoprostenol Overall Market Size
2.1 China Epoprostenol Market Size: 2021 VS 2027
2.2 China Epoprostenol Revenue, Prospects & Forecasts: 2016-2027
2.3 China Epoprostenol Sales: 2016-2027
3 Company Landscape
3.1 Top Epoprostenol Players in China Market
3.2 Top China Epoprostenol Companies Ranked by Revenue
3.3 China Epoprostenol Revenue by Companies
3.4 China Epoprostenol Sales by Companies
3.5 China Epoprostenol Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Epoprostenol Companies in China Market, by Revenue in 2020
3.7 Manufacturers Epoprostenol Product Type
3.8 Tier 1, Tier 2 and Tier 3 Epoprostenol Players in China Market
3.8.1 List of Tier 1 Epoprostenol Companies in China
3.8.2 List of Tier 2 and Tier 3 Epoprostenol Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Epoprostenol Market Size Markets, 2021 & 2027
4.1.2 Oral Epoprostenol
4.1.3 Injection Epoprostenol
4.2 By Type - China Epoprostenol Revenue & Forecasts
4.2.1 By Type - China Epoprostenol Revenue, 2016-2021
4.2.2 By Type - China Epoprostenol Revenue, 2022-2027
4.2.3 By Type - China Epoprostenol Revenue Market Share, 2016-2027
4.3 By Type - China Epoprostenol Sales & Forecasts
4.3.1 By Type - China Epoprostenol Sales, 2016-2021
4.3.2 By Type - China Epoprostenol Sales, 2022-2027
4.3.3 By Type - China Epoprostenol Sales Market Share, 2016-2027
4.4 By Type - China Epoprostenol Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Sale Channel
5.1 Overview
5.1.1 By Sale Channel - China Epoprostenol Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Sale Channel - China Epoprostenol Revenue & Forecasts
5.2.1 By Sale Channel - China Epoprostenol Revenue, 2016-2021
5.2.2 By Sale Channel - China Epoprostenol Revenue, 2022-2027
5.2.3 By Sale Channel - China Epoprostenol Revenue Market Share, 2016-2027
5.3 By Sale Channel - China Epoprostenol Sales & Forecasts
5.3.1 By Sale Channel - China Epoprostenol Sales, 2016-2021
5.3.2 By Sale Channel - China Epoprostenol Sales, 2022-2027
5.3.3 By Sale Channel - China Epoprostenol Sales Market Share, 2016-2027
5.4 By Sale Channel - China Epoprostenol Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Actelion
6.1.1 Actelion Corporation Information
6.1.2 Actelion Overview
6.1.3 Actelion Epoprostenol Sales and Revenue in China Market (2016-2021)
6.1.4 Actelion Epoprostenol Product Description
6.1.5 Actelion Recent Developments
6.2 Glaxosmithkline Inc
6.2.1 Glaxosmithkline Inc Corporation Information
6.2.2 Glaxosmithkline Inc Overview
6.2.3 Glaxosmithkline Inc Epoprostenol Sales and Revenue in China Market (2016-2021)
6.2.4 Glaxosmithkline Inc Epoprostenol Product Description
6.2.5 Glaxosmithkline Inc Recent Developments
6.3 Sandoz Canada Incorporated
6.3.1 Sandoz Canada Incorporated Corporation Information
6.3.2 Sandoz Canada Incorporated Overview
6.3.3 Sandoz Canada Incorporated Epoprostenol Sales and Revenue in China Market (2016-2021)
6.3.4 Sandoz Canada Incorporated Epoprostenol Product Description
6.3.5 Sandoz Canada Incorporated Recent Developments
6.4 Teva Parenteral
6.4.1 Teva Parenteral Corporation Information
6.4.2 Teva Parenteral Overview
6.4.3 Teva Parenteral Epoprostenol Sales and Revenue in China Market (2016-2021)
6.4.4 Teva Parenteral Epoprostenol Product Description
6.4.5 Teva Parenteral Recent Developments
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Overview
6.5.3 Bayer AG Epoprostenol Sales and Revenue in China Market (2016-2021)
6.5.4 Bayer AG Epoprostenol Product Description
6.5.5 Bayer AG Recent Developments
6.6 SteadyMed
6.6.1 SteadyMed Corporation Information
6.6.2 SteadyMed Overview
6.6.3 SteadyMed Epoprostenol Sales and Revenue in China Market (2016-2021)
6.6.4 SteadyMed Epoprostenol Product Description
6.6.5 SteadyMed Recent Developments
6.7 Reata Pharmaceuticals
6.7.1 Reata Pharmaceuticals Corporation Information
6.7.2 Reata Pharmaceuticals Overview
6.7.3 Reata Pharmaceuticals Epoprostenol Sales and Revenue in China Market (2016-2021)
6.7.4 Reata Pharmaceuticals Epoprostenol Product Description
6.7.5 Reata Pharmaceuticals Recent Developments
6.8 Arena Pharmaceuticals
6.8.1 Arena Pharmaceuticals Corporation Information
6.8.2 Arena Pharmaceuticals Overview
6.8.3 Arena Pharmaceuticals Epoprostenol Sales and Revenue in China Market (2016-2021)
6.8.4 Arena Pharmaceuticals Epoprostenol Product Description
6.8.5 Arena Pharmaceuticals Recent Developments
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Overview
6.9.3 Merck Epoprostenol Sales and Revenue in China Market (2016-2021)
6.9.4 Merck Epoprostenol Product Description
6.9.5 Merck Recent Developments
7 China Epoprostenol Production Capacity, Analysis
7.1 China Epoprostenol Production Capacity, 2016-2027
7.2 Epoprostenol Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Epoprostenol Supply Chain Analysis
9.1 Epoprostenol Industry Value Chain
9.2 Epoprostenol Upstream Market
9.3 Epoprostenol Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Epoprostenol Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Epoprostenol in China Market
Table 2. Top Epoprostenol Players in China Market, Ranking by Revenue (2019)
Table 3. China Epoprostenol Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Epoprostenol Revenue Share by Companies, 2016-2021
Table 5. China Epoprostenol Sales by Companies, (MT), 2016-2021
Table 6. China Epoprostenol Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Epoprostenol Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Epoprostenol Product Type
Table 9. List of Tier 1 Epoprostenol Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Epoprostenol Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral Epoprostenol
Table 12. Major Manufacturers of Injection Epoprostenol
Table 13. By Type - China Epoprostenol Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Epoprostenol Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Epoprostenol Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Epoprostenol Sales (MT), 2016-2021
Table 17. By Type - China Epoprostenol Sales (MT), 2022-2027
Table 18. By Sale Channel - China Epoprostenol Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Sale Channel - China Epoprostenol Revenue (US$, Mn), 2016-2021
Table 20. By Sale Channel - China Epoprostenol Revenue (US$, Mn), 2022-2027
Table 21. By Sale Channel - China Epoprostenol Sales (MT), 2016-2021
Table 22. By Sale Channel - China Epoprostenol Sales (MT), 2022-2027
Table 23. Actelion Corporation Information
Table 24. Actelion Description and Major Businesses
Table 25. Actelion Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Actelion Epoprostenol Product
Table 27. Actelion Recent Developments
Table 28. Glaxosmithkline Inc Corporation Information
Table 29. Glaxosmithkline Inc Description and Major Businesses
Table 30. Glaxosmithkline Inc Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Glaxosmithkline Inc Epoprostenol Product
Table 32. Glaxosmithkline Inc Recent Developments
Table 33. Sandoz Canada Incorporated Corporation Information
Table 34. Sandoz Canada Incorporated Description and Major Businesses
Table 35. Sandoz Canada Incorporated Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Sandoz Canada Incorporated Epoprostenol Product
Table 37. Sandoz Canada Incorporated Recent Developments
Table 38. Teva Parenteral Corporation Information
Table 39. Teva Parenteral Description and Major Businesses
Table 40. Teva Parenteral Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Teva Parenteral Epoprostenol Product
Table 42. Teva Parenteral Recent Developments
Table 43. Bayer AG Corporation Information
Table 44. Bayer AG Description and Major Businesses
Table 45. Bayer AG Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Bayer AG Epoprostenol Product
Table 47. Bayer AG Recent Developments
Table 48. SteadyMed Corporation Information
Table 49. SteadyMed Description and Major Businesses
Table 50. SteadyMed Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. SteadyMed Epoprostenol Product
Table 52. SteadyMed Recent Developments
Table 53. Reata Pharmaceuticals Corporation Information
Table 54. Reata Pharmaceuticals Description and Major Businesses
Table 55. Reata Pharmaceuticals Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Reata Pharmaceuticals Epoprostenol Product
Table 57. Reata Pharmaceuticals Recent Developments
Table 58. Arena Pharmaceuticals Corporation Information
Table 59. Arena Pharmaceuticals Description and Major Businesses
Table 60. Arena Pharmaceuticals Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Arena Pharmaceuticals Epoprostenol Product
Table 62. Arena Pharmaceuticals Recent Developments
Table 63. Merck Corporation Information
Table 64. Merck Description and Major Businesses
Table 65. Merck Epoprostenol Sales (MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 66. Merck Epoprostenol Product
Table 67. Merck Recent Developments
Table 68. Epoprostenol Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT)
Table 69. China Epoprostenol Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Epoprostenol Market Opportunities & Trends in China Market
Table 71. Epoprostenol Market Drivers in China Market
Table 72. Epoprostenol Market Restraints in China Market
Table 73. Epoprostenol Raw Materials
Table 74. Epoprostenol Raw Materials Suppliers in China Market
Table 75. Typical Epoprostenol Downstream
Table 76. Epoprostenol Downstream Clients in China Market
Table 77. Epoprostenol Distributors and Sales Agents in China Market
List of FiguresFigure 1. Epoprostenol Product Picture
Figure 2. Epoprostenol Segment by Type
Figure 3. Epoprostenol Segment by Sale Channel
Figure 4. China Epoprostenol Market Overview: 2020
Figure 5. China Epoprostenol Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Epoprostenol Revenue, 2016-2027 (US$, Mn)
Figure 7. Epoprostenol Sales in China Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Epoprostenol Revenue in 2020
Figure 9. Oral Epoprostenol Product Picture
Figure 10. Injection Epoprostenol Product Picture
Figure 11. By Type - China Epoprostenol Sales Market Share, 2016-2027
Figure 12. By Type - China Epoprostenol Revenue Market Share, 2016-2027
Figure 13. By Type - China Epoprostenol Price (USD/MT), 2016-2027
Figure 14. Hospital Pharmacy
Figure 15. Retail Pharmacy
Figure 16. Online Pharmacy
Figure 17. By Sale Channel - China Epoprostenol Sales Market Share, 2016-2027
Figure 18. By Sale Channel - China Epoprostenol Revenue Market Share, 2016-2027
Figure 19. By Sale Channel - China Epoprostenol Price (USD/MT), 2016-2027
Figure 20. Actelion Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Glaxosmithkline Inc Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sandoz Canada Incorporated Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Teva Parenteral Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Bayer AG Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. SteadyMed Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Reata Pharmaceuticals Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Arena Pharmaceuticals Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Merck Epoprostenol Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. China Epoprostenol Production Capacity (MT), 2016-2027
Figure 30. Epoprostenol Industry Value Chain
Figure 31. Marketing Channels